Condition

Castleman's Disease clinical trials and research

As of November 12, 2026, Find a Trial lists 4 Castleman's Disease clinical trials that are recruiting, at sites in 2 countries (most in United States (3), China (1)). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.

Newest Castleman's Disease clinical trials

StudyPhaseWhereStatusRegistered
Cohort of patients with plasma cell disorders at Peking University First Hospital — Beijing Recruiting Mar 17, 2022
Registry for adults with plasma cell disorders — Chapel Hill, North Carolina Recruiting Oct 24, 2018
Exploring genetic factors in viral-associated tumors and immune disorders — Bethesda, Maryland Recruiting Oct 4, 2017
Registry for Patients with Castleman Disease — Philadelphia, Pennsylvania Recruiting Jun 29, 2016

All recruiting trials (4)

Related topics

AmyloidosisMultiple MyelomaPlasma Cell LeukemiaSmoldering Multiple MyelomaHuman Immunodeficiency VirusMonoclonal Gammopathy of Undetermined Significance (MGUS)

Quick answers

How many Castleman's Disease clinical trials are recruiting right now?

4, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

In 2 countries. The most sites are in United States (3 trials), China (1 trial). Each study page lists its sites and which ones are recruiting.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →

Last reviewed 2026-11-12 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.